Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Study for the Evaluation of the Safety, Pharmacokinetics and Antitumor Activity of SAR408701 in Patients With Advanced Solid Tumors

NCT02187848 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02187848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02187848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Study for the Evaluation of the Safety, Pharmacokinetics and Antitumor Activity of SAR408701 in Patients With Advanced Solid Tumors
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Terminated
Start date
July 23, 2014
Completion date
November 19, 2024
Enrollment
254 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm malignant